— Know what they know.
Not Investment Advice
Also trades as: KHRWF (OTC) · $vol 0M · KHRN.V (TSXV) · $vol 0M

KHRNF OTC

Khiron Life Sciences Corp.
1W: +900.0% 1M: +900.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 61 · $2324 mcap · 205M float · 0.0069% daily turnover

Balance Sheet Trends

Total Assets
$42M -42.2% ▼
5Y CAGR: +474.4%
Total Liabilities
$9M -10.1% ▼
5Y CAGR: +143.9%
Shareholders Equity
$33M -47.3% ▼
Cash & Investments
$9M -58.8% ▼
5Y CAGR: +1370.0%
Total Debt
$2M -20.2% ▼
Net Debt
-$7M +64.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2017FY2018FY2019FY2020FY2021
— Assets —
Cash$148K$15M$9M$22M$9M
Short-Term Investments$0$4M$28M$0$0
Cash & ST Investments$148K$19M$37M$22M$9M
Net Receivables$0$3M$4M$5M$3M
Inventory$0$238K$961K$8M$9M
Other Current Assets$0$1M$0-$86$0
Total Current Assets$148K$24M$45M$36M$24M
Property, Plant & Equip.$0$10M$16M$18M$14M
Goodwill & Intangibles$0$7M$20M$19M$5M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$153K$1M$0$0
Total Non-Current Assets$0$16M$37M$37M$18M
Total Assets$148K$40M$82M$73M$42M
— Liabilities —
Accounts Payable$13K$6M$7M$6M$4M
Short-Term Debt$0$156K$566K$500K$735K
Deferred Revenue$0$0-$441K$0$0
Other Current Liabilities$0$0$882K$306$2M
Total Current Liabilities$13K$7M$8M$7M$8M
Long-Term Debt$0$1M$0$0$0
Other Non-Current Liab.$0$4M$3M$2M$523K
Total Non-Current Liabilities$0$8M$3M$3M$1M
Total Liabilities$13K$15M$12M$10M$9M
— Equity —
Common Stock$624K$40M$121M$137M$146M
Retained Earnings-$524K-$24M-$60M-$84M-$117M
Accumulated OCI$35K-$454K$9M$10M$4M
Total Stockholders Equity$135K$26M$70M$63M$33M
Total Liabilities & Equity$148K$40M$82M$73M$42M
— Key Metrics —
Total Debt$0$3M$4M$3M$2M
Net Debt-$148K-$13M-$6M-$19M-$7M
Total Investments$0$4M$28M$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms